SEC Form 4 · accession 0000903423-15-000157
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
GLAXOSMITHKLINE PLC
Other
Period of report
Feb 23, 2015
Accepted (ET)
Feb 24, 2015 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2015 | S | 503,150 | $22.0006 | D | 1,436,448 | I | By S.R. One Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline PLC (Reporting Person).